The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
National survival trends of young adults with sarcoma: Lack of progress is associated with lack of clinical trial participation
Open accessAbstract
BACKGROUND: Young adults with cancer in the U.S. have had less improvement in survival than either younger patients or older patients. The authors attempted to determine whether similar deficits have occurred in young adults with sarcomas and, if so, then why. METHODS: In 38,144 young adults with sarcoma who were diagnosed during 1975–1998 and were followed by the National Cancer Institute's (NCI) Surveillance, Epidemiology, and End Results Program, the average annual percent change in 5‐year survival was derived as a function of patient age. National sarcoma treatment trial data were obtained on 3242 patients who were entered onto NCI‐sponsored trials during 1997–2002. RESULTS: 1) For patients with bone and soft‐tissue sarcomas, except Kaposi sarcoma (KS), the least survival improvement occurred between age 15 years and age 45 years. For patients with KS, the pattern was reversed, with the greatest survival increase occurring among patients ages 30–44 years. 2) The lowest participation rate in NCI‐sponsored sarcoma treatment trials occurred in patients ages 20–44 years. For patients with KS, the highest accrual rate occurred in patients ages 35–44 years. 3) The age‐dependent survival improvement and clinical‐trial accrual patterns were correlated directly (soft‐tissue sarcomas, P < 0.005; bone sarcomas, P < 0.05; KS, P = 0.06), regardless of whether the accrual profile demonstrated a decline or a peak (KS) during early adulthood. CONCLUSIONS: The lack of survival prolongation in patients age 15–44 years in the U.S. with non‐KS sarcomas may have been a result of their relative lack of participation in clinical trials. If this is true, then reversing the shortfall in survival among young adults with sarcomas, as was accomplished among patients with KS, should benefit from increased clinical trial availability, access, and participation. Cancer 2005. Published 2005 by the American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meyers, P. A., & Gorlick, R. (1997) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70540-x · Cited by 299
Research works printed but not linked: 23
- Bleyer A, 2002, United States cancer incidence, mortality and survival: young adults are lagging further behind, Proc Am Soc Clin Oncol., 21, 389a
- 10.1002/mpo.1257 · DOI · Paper page
- Bleyer A, 2002, U.S. cancer incidence, mortality and survival: young adults are lagging further behind
- Bleyer A, 2004, Young adults with leukemia in the United States: Lack of clinical trial participation and mortality reduction during the last decade, Proc Am Soc Clin Oncol., 23, 586
- Bleyer A, 2004, Older adolescents and young adults with brain tumors in the United States: lack of clinical trial participation and of survival prolongation and mortality reduction, Proc Intl Symp Pediatr Neurooncol., 52
- 10.5694/j.1326-5377.2004.tb05799.x · DOI
- Bleyer A, 2003, Young Adults with sarcoma: lack of clinical trial participation and lack of survival prolongation, Proc Am Soc Clin Oncol., 22, 816
- Ries LAG, 2003, SEER cancer statistics review, 1975–2000
- Bleyer A, 2003, Holland‐Frei: cancer medicine, 2414
- General Accounting Office, 2000, Analysis of the March 2000 current population survey of nonelderly (under 65)
- 10.1016/S0031-3955(02)00035-4 · DOI
- 10.1002/mpo.10240 · DOI · Paper page
- 10.1097/00043426-199907000-00022 · DOI
- 10.1200/JCO.2003.02.026 · DOI · Paper page
- Paulussen S, 2003, Cure rates in Ewing tumor patients aged over 15 years are better in pediatric oncology units. Results of GPOH CESS/EICESS studies, Proc Am Soc Clin Oncol., 22, 816
- 10.1002/1097-0142(19930515)71:10 <3377::AID-CNCR2820711741>3.0.CO;2-8 · doi:10.1002/1097-0142(19930515)71:10
- Stock W, 2000, Outcome of adolescents and young adults with ALL: a comparison of Children's Cancer Group (CCG) and Cancer and Leukemia Group G (CALGB) regimens, Blood., 96, 467a
- 10.1038/sj.leu.2403538 · DOI · Paper page
- 10.1200/JCO.2003.02.053 · DOI · Paper page
- 10.1002/cncr.11550 · DOI · Paper page
- 10.1016/S1054-139X(97)00110-9 · DOI · Paper page
- 10.1093/jnci/88.12.812 · DOI · Paper page
- 10.5694/j.1326-5377.2004.tb05795.x · doi:10.5694/j.1326-5377.2004.tb05795.x
Cited by
Cancer statistics for adolescents and young adults, 2020
Miller, K. D., Fidler‐Benaoudia, M., Keegan, T. H., Hipp, H. S., Jemal, A., & Siegel, R. L. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21637 · Cited by 1,190
Challenges in the recruitment of adolescents and young adults to cancer clinical trials
Burke, M. E., Albritton, K., & Marina, N. (2007) · Cancer · doi:10.1002/cncr.23060 · Cited by 181
Cancer in Young Adults 20 to 39 Years of Age: Overview
Bleyer, A., & Barr, R. (2009) · Seminars in Oncology · doi:10.1053/j.seminoncol.2009.03.003 · Cited by 144
Self-citationFreyer, D. R., & Seibel, N. L. (2015) · Current Pediatrics Reports · doi:10.1007/s40124-015-0075-y · Cited by 65
Management of sarcoma in the Asia-Pacific region: resource-stratified guidelines.
Lewin, J., Puri, A., Quek, R., Ngan, R., Alcasabas, A. P., Wood, D., & Thomas, D. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70475-3 · Cited by 44
Metadata
- Authors
- Bleyer, A., Montello, M., Budd, T., & Saxman, S.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2005-04-18
- Volume
- 103
- Issue
- 9
- Pages
- 1891-1897
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1576736872
- Cited by
- 174
- References
- 1
- FWCI
- 6.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: National survival trends of young adults with sarcoma: Lack of progress is associated with lack of clinical trial participation. https://app.cochat.ai/papers/10.1002/cncr.20995
- The paper
- Bleyer, A., Montello, M., Budd, T., & Saxman, S. (2005). National survival trends of young adults with sarcoma: Lack of progress is associated with lack of clinical trial participation. Cancer. https://doi.org/10.1002/cncr.20995
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
